We are live on ! Find out more
NPCE icon

Neuropace
NPCE

44 hedge funds and large institutions have $259M invested in Neuropace in 2021 Q2 according to their latest regulatory filings, with 44 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

44.9% more ownership

Funds ownership: 0% → 44.9% (+45%)

Holders
44
Holders Change
+44
Holders Change %
–
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
44
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$93.1M
2
SCM
Soleus Capital Management
Connecticut
+$32.1M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$24.6M
4
BG
Bellevue Group
Switzerland
+$11.8M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
+$11.3M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
N
26
Nuveen
North Carolina
$262K +$255K +11,008 New
Wells Fargo
27
Wells Fargo
California
$243K +$237K +10,221 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$228K +$223K +9,587 New
Jane Street
29
Jane Street
New York
$215K +$210K +9,037 New
JP Morgan Chase
30
JP Morgan Chase
New York
$191K +$186K +7,993 New
Morgan Stanley
31
Morgan Stanley
New York
$181K +$176K +7,592 New
New York State Common Retirement Fund
32
New York State Common Retirement Fund
New York
$143K +$139K +6,000 New
Deutsche Bank
33
Deutsche Bank
Germany
$98K +$95.9K +4,133 New
UBS Group
34
UBS Group
Switzerland
$61K +$59.5K +2,563 New
Bank of America
35
Bank of America
North Carolina
$48K +$47.3K +2,037 New
SO
36
STRS Ohio
Ohio
$38K +$37.1K +1,600 New
TRCT
37
Tower Research Capital (TRC)
New York
$32K +$31.2K +1,343 New
Osaic Holdings
38
Osaic Holdings
Arizona
$17K +$16.2K +700 New
Legal & General Group
39
Legal & General Group
United Kingdom
$17K +$16.9K +730 New
AIP
40
Ameritas Investment Partners
Nebraska
$13K +$12.7K +546 New
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$11K +$11.1K +477 New
BWM
42
BerganKDV Wealth Management
Minnesota
$10K +$9.75K +420 New
Citigroup
43
Citigroup
New York
$8K +$7.68K +331 New
AIG
44
American International Group
New York
$93 +$90.6K +3,902 New
1
2

NPCE Hedge Fund Activity: Q2 2021 in Review

44 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Neuropace (NPCE) for Q2 2021, worth a combined $259M.

Buyers outnumbered sellers: 44 funds opened new NPCE positions and 0 closed out — a net gain of 44 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $93.1M.

  • 44 institutional investors held Neuropace (NPCE) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $259M of Neuropace stock for Q2 2021.
  • 44 funds opened new Neuropace positions in Q2 2021 and 0 closed out, a net change of +44 holders.
  • The largest Neuropace buyer in Q2 2021 was OrbiMed, an estimated $93.1M added.

Based on aggregated 13F filings for Q2 2021.